The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Obesity and Nonalcoholic Fatty Liver Disease
Nurs Clin North Am. 2021 Dec;56(4):543-552. doi: 10.1016/j.cnur.2021.07.009.
1Department of Transplant, Mayo Clinic College of Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA. Electronic address: CHANEY.AMANDA@MAYO.EDU.
Abstract
Obesity and nonalcoholic fatty liver disease (NAFLD) have a significant global impact, and their complications are quickly becoming a reason for primary care visits and hospitalizations. This article provides an overview of NAFLD and obesity, pathogenesis of NAFLD and nonalcoholic steatohepatitis, clinical presentation and diagnostic criteria, and a review of practice guidelines. The current mainstay of treatment for NAFLD are lifestyle modifications and include a plan to eat, move, and change behavior. The future holds potential for new drug therapies in treating NAFLD. More research is needed to move these treatments forward.